Manufacturing
Published: January 28, 2025 | Updated: 28th January 2025
Curium, the Paris-headquartered nuclear medicine provider with offices across Europe and the US, has opted for larger premises at Lakeside North Harbour in Portsmouth.
The firm’s UK operation has been based at the Hampshire business campus since last July.
It develops, manufactures and distributes radiopharmaceutical products to support the treatment of potentially life-threatening diseases for more than 14 million patients a year.
The bigger space at Lakeside will used for customer services, sales and operations.
Simon Bateman, asset manager, said: “Curium extending their contract at Lakeside and opting to move to a bigger space is a testament to Lakeside and what we have to offer to our occupiers.
“Lakeside’s flexible workspaces and its thriving and supportive work environment meet our occupiers’ needs perfectly, and I hope that the team at Curium continue to enjoy what we have to offer.”
Kathryn Thomas at Curium Pharma added: “This expansion reflects our continued focus on the patients we serve.
“By remaining at Lakeside and in larger premises, we ensure a modern and convenient space for our team while continuing to support our customers.
“With Lakeside’s excellent employee accessibility and its wide range of amenities, our commitment to delivering outstanding customer service to our clients will continue from our new office.”
